Combined Treatments for Facial Contouring
(US Harmony Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are using weight loss medications, you cannot continue them during the study.
What data supports the effectiveness of the treatment for facial contouring?
Research shows that botulinum toxin A, a component of the treatment, is effective in reducing facial lines and improving the appearance of the neck, which suggests it may help with facial contouring. Additionally, studies on similar treatments have shown positive results in reducing wrinkles and enhancing facial features.12345
Is the combined treatment for facial contouring safe?
How is the Combined Treatments for Facial Contouring different from other treatments?
This treatment is unique because it combines multiple approaches, including CoolSculpting Elite System, JUVÉDERM, KYBELLA, and OnabotulinumtoxinA, to target facial contouring. The combination of these treatments can provide enhanced results by addressing different aspects of facial aesthetics, such as fat reduction, volume enhancement, and wrinkle smoothing, in a single comprehensive approach.311121314
What is the purpose of this trial?
A study to evaluate overall participant satisfaction of face and neck appearance after treatment with onabotulinumtoxinA, JUVÉDERM® products, KYBELLA, CoolSculpting Elite, and select SkinMedica products in a diverse population.
Research Team
ABBVIE INC.
Principal Investigator
AbbVie
Eligibility Criteria
This trial is for individuals seeking to improve their facial and neck appearance. Specific eligibility criteria are not provided, but typically participants should be in good health with realistic expectations about cosmetic procedures.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive treatment with onabotulinumtoxinA, JUVÉDERM products, KYBELLA, CoolSculpting Elite, and select SkinMedica products
Follow-up
Participants are monitored for satisfaction with facial and neck appearance, psychological function, social function, and skin quality
Treatment Details
Interventions
- CoolSculpting Elite System
- JUVÉDERM
- KYBELLA
- OnabotulinumtoxinA
- SkinMedica Products
Find a Clinic Near You
Who Is Running the Clinical Trial?
AbbVie
Lead Sponsor
Dr. Roopal Thakkar
AbbVie
Chief Medical Officer since 2023
MD from Wayne State University School of Medicine
Robert A. Michael
AbbVie
Chief Executive Officer
Bachelor's degree in Finance from the University of Illinois